Real-world experience for the outcomes and costs of treating hepatitis C patients: Results from the German Hepatitis C-Registry (DHC-R).

Kathrin Krüger,Siegbert Rossol,Christian Krauth,Peter Buggisch,Stefan Mauss,Albrecht Stoehr,Hartwig Klinker,Klaus Böker,Gerlinde Teuber,Jona Stahmeyer

Zeitschrift fur Gastroenterologie（2022）

引用 3|浏览4

暂无评分

摘要

Over time, some relevant factors developed positively (SVR-rates, costs, treatment duration, adverse events, health-related quality of life (HRQoL)). Further research on HRQoL, especially on mental health, is necessary to evaluate the differences between subgroups and HRQoL over time and to identify influencing factors.

查看译文

关键词

liver,viral hepatitis,hepatitis C,clinical practice,registry data,SVR,quality of life,HIV,drug users,costs

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要